News
Eli Lilly (NYSE: LLY) sells a broad range of medicines, from cancer and immunology drugs to treatments for migraine. Right ...
Camurus licensed its FluidCrystal drug delivery tech to Eli Lilly for global development of long-acting incretin therapies ...
With IRS tax refunds set to arrive, averaging around $3,000, many Americans are weighing the best ways to use the extra cash.
Income investing isn’t meant to create fabulous wealth in a month or even a year. After a quarter-century of successful ...
There’s more than one way to build a portfolio of dividend stocks. The classic move is to buy some individual large-cap ...
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
Eli Lilly's growth is impressive, but its current valuation is only justifiable with sustained high growth. Click here to ...
We analyzed five Dividend Aristocrats in an underrated sector to see which one stands out the most. See who won.
Representative Marjorie Taylor Greene recently bought between $1,001 and $15,000 in Blackstone shares, adding to her recent ...
Zacks Research just spiced up Eli Lilly’s Q2 2025 earnings estimate, bumping it to $5.53 per share from $5.48. Other analysts ...
Wegovy-maker Novo Nordisk ousted CEO Lars Fruergaard Jorgensen on Friday over concerns the company is losing its first-mover ...
INDIANAPOLIS - Eli Lilly and Company (NYSE:LLY), a global pharmaceutical firm, has announced a second-quarter dividend of $1.50 per share on its outstanding common stock. Shareholders on record as of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results